TNXP Price / Book | TONIX PHARMACEUTICALS HOLDING CORP.

TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Price / Book

2026-09-03: Price/Book Ratio 1.03.
2026-06-30: Price/Book Ratio 0.96.
2026-03-31: Price/Book Ratio 0.86.
2025-12-31: Price/Book Ratio 0.81.

Historical market capitalization divided by filed shareholder equity.

Available history: 2012-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	1.03
2026-06-30	0.96
2026-03-31	0.86
2025-12-31	0.81
2025-09-30	1.06
2025-06-30	1.62
2025-03-31	0.68
2024-12-31	1.04
2024-09-30	31.46
2024-06-30	16.35
2024-03-31	414.49
2023-12-31	0.25
2023-09-30	258.72
2023-06-30	387.39
2023-03-31	4,542.88
2022-12-31	465.65
2022-09-30	2,468.98
2022-06-30	4,386.98
2022-03-31	391,312.62
2021-12-31	16,473.61
2021-09-30	766,551.4
2021-06-30	1,363,227.62
2021-03-31	1,499,883.59
2020-12-31	1,022,898.17
2020-09-30	1,204,286.09
2020-06-30	62,172.39
2020-03-31	717,702.95
2019-12-31	678,389.1
2019-09-30	409,196.32
2019-06-30	4,334,299.62
2019-03-31	5,273,592.99
2018-12-31	195,568.84
2018-09-30	28,867,314.8
2018-06-30	158,559,766.29
2018-03-31	82,643,150.82
2017-12-31	7,049,113.55
2017-09-30	77,149,348.95
2017-06-30	61,104,849.87
2017-03-31	56,590,857.26
2016-12-31	46,484,351.75
2016-09-30	485,150,992.95
2016-06-30	1,063,502,009.72
2016-03-31	1,065,838,232.26
2015-12-31	229,598,384.82
2015-09-30	1,210,926,640.83
2015-06-30	2,003,383,029.98
2015-03-31	1,147,462,817.4
2014-12-31	1,118,962,381.47
2014-09-30	1,074,949,048.86
2014-06-30	2,138,234,706.17
2014-03-31	1,376,658,595.03
2013-12-31	5,900,340,551.35
2013-09-30	2,095,973,866.31
2012-12-31	15,850,343,441.08
2012-06-30	613,747,693,151.28

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Minerva Neurosciences, Inc. (NERV)	United States	$0.165B	-0.66
ADC Therapeutics SA (ADCT)		$0.163B	-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)	United States	$0.163B	-8.50
Organogenesis Holdings Inc. (ORGO)	United States	$0.182B	-3.70
AN2 Therapeutics, Inc. (ANTX)	United States	$0.185B	-4.84
Annexon, Inc. (ANNX)	United States	$0.147B	-4.22
PepGen Inc. (PEPG)	United States	$0.186B	-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)	United States	$0.144B	-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)	United States	$0.187B	-3.52
Fortress Biotech, Inc. (FBIO)	United States	$0.188B	0.91